← Eichor
Study identifier: NCT06933381 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Vapocoolant Spray to Reduce Pain With Nexplanon Insertion

Condition: Reducing Pain With Nexplanon Implant Insertion  ·  Sponsor: Queen's Medical Center

PhaseNA
Planned participants70
Who can joinFemale, 14 Years to no upper limit
Healthy volunteersYes

About this study

The purpose of this study is to assess if Pain Ease vapocoolant spray decreases pain associated with lidocaine injection during Nexplanon insertion procedures.

This description comes directly from the study's public registry record.

Talk to the study team

Sarah Murayama, MD  ·  808-783-0298  ·  smura@hawaii.edu

Mary Tschann, PhD  ·  808-375-3785  ·  mtschann@hawaii.edu

Always discuss trial participation with your own doctor first.

Locations (3)

Queens Medical Center POB 2 Suite 402Honolulu, Hawaii, United StatesRecruiting
Queens Medical Center POB1 Clinic 1004Honolulu, Hawaii, United StatesRecruiting
Women's Center Queen's North Hawai'i Community Hospital Suite #124 and #120Waimea, Hawaii, United StatesNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06933381